HEADER TRANSFERASE 15-DEC-04 2BFY TITLE COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN. COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE B-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 78-361; COMPND 5 SYNONYM: LOC398457 PROTEIN, AURORA-B, AURORA/IPL1-RELATED KINASE 2-A, COMPND 6 AIRK2-A, XAIRK2-A, SERINE/THREONINE-PROTEIN KINASE 12-A, COMPND 7 SERINE/THREONINE-PROTEIN KINASE AURORA-B-A, XAURORA-B; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 OTHER_DETAILS: PHOSPHORYLATED ON T248; COMPND 12 MOL_ID: 2; COMPND 13 MOLECULE: INNER CENTROMERE PROTEIN A; COMPND 14 CHAIN: C, D; COMPND 15 FRAGMENT: RESIDUES 798-840; COMPND 16 SYNONYM: INCENP, XL-INCENP, XINC, XINCENP, MITOTIC PHOSPHOPROTEIN COMPND 17 130; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 3 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 4 ORGANISM_TAXID: 8355; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 10 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 11 ORGANISM_TAXID: 8355; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS TRANSFERASE, KINASE, MITOSIS, INHIBITION, TRANSFERASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.SESSA,M.MAPELLI,C.CIFERRI,C.TARRICONE,L.B.ARECES,T.R.SCHNEIDER, AUTHOR 2 P.T.STUKENBERG,A.MUSACCHIO REVDAT 5 13-DEC-23 2BFY 1 REMARK LINK REVDAT 4 20-MAY-15 2BFY 1 COMPND REVDAT 3 14-MAY-14 2BFY 1 TITLE COMPND SOURCE KEYWDS REVDAT 3 2 1 AUTHOR JRNL REMARK VERSN REVDAT 3 3 1 DBREF HETSYN FORMUL MASTER REVDAT 2 24-FEB-09 2BFY 1 VERSN REVDAT 1 03-MAY-05 2BFY 0 JRNL AUTH F.SESSA,M.MAPELLI,C.CIFERRI,C.TARRICONE,L.B.ARECES, JRNL AUTH 2 T.R.SCHNEIDER,P.T.STUKENBERG,A.MUSACCHIO JRNL TITL MECHANISM OF AURORA B ACTIVATION BY INCENP AND INHIBITION BY JRNL TITL 2 HESPERADIN JRNL REF MOL.CELL V. 18 379 2005 JRNL REFN ISSN 1097-2765 JRNL PMID 15866179 JRNL DOI 10.1016/J.MOLCEL.2005.03.031 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1263449.930 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 64077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3270 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9313 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 519 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5179 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 383 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.48000 REMARK 3 B22 (A**2) : 6.78000 REMARK 3 B33 (A**2) : -7.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.39000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.09 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.310 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 53.52 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : TPO.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : HESPERIDIN.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : TPO.TOP REMARK 3 TOPOLOGY FILE 4 : HESPERIDIN.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BFY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1290021973. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 287.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67250 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.01000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.02000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1OL5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS TRIS PROPANE PH 6.6, 18% REMARK 280 PEG3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.52200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE CHAINS A, B GLY 96 VAL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 78 REMARK 465 ALA A 79 REMARK 465 LEU A 80 REMARK 465 ALA A 81 REMARK 465 GLU A 82 REMARK 465 MET A 83 REMARK 465 PRO A 84 REMARK 465 LYS A 85 REMARK 465 THR A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 LYS A 361 REMARK 465 THR B 358 REMARK 465 GLN B 359 REMARK 465 SER B 360 REMARK 465 LYS B 361 REMARK 465 ILE C 798 REMARK 465 PRO C 799 REMARK 465 LYS C 839 REMARK 465 SER C 840 REMARK 465 ILE D 798 REMARK 465 PRO D 799 REMARK 465 ALA D 800 REMARK 465 TRP D 801 REMARK 465 ALA D 802 REMARK 465 SER D 803 REMARK 465 GLY D 804 REMARK 465 LYS D 839 REMARK 465 SER D 840 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 357 CA C O CB OG REMARK 470 SER B 357 CA C O CB OG REMARK 470 SER C 803 OG REMARK 470 ASN C 838 CA C O CB CG OD1 ND2 REMARK 470 ASN D 838 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TPO A 248 C MET A 249 N 0.287 REMARK 500 TPO B 248 C MET B 249 N 0.289 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TPO B 248 O - C - N ANGL. DEV. = -11.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 136 22.58 -79.14 REMARK 500 ASN A 158 -174.98 -176.71 REMARK 500 ASP A 216 47.62 -149.49 REMARK 500 ALA A 241 76.46 -118.04 REMARK 500 SER A 243 -74.31 -137.19 REMARK 500 LEU A 253 -62.69 -29.46 REMARK 500 GLN A 356 -153.73 151.55 REMARK 500 ARG B 97 150.87 179.64 REMARK 500 GLN B 128 25.98 -71.62 REMARK 500 LEU B 129 -32.69 -133.09 REMARK 500 ASN B 158 -173.56 -173.04 REMARK 500 ASP B 216 43.48 -146.54 REMARK 500 TRP C 801 -155.31 -90.10 REMARK 500 LYS C 817 64.22 -119.48 REMARK 500 TYR D 825 -37.48 -131.61 REMARK 500 PHE D 837 -62.29 -124.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H1N A 1357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H1N B 1357 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BFX RELATED DB: PDB REMARK 900 MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY REMARK 900 HESPERADIN. DBREF 2BFY A 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 2BFY B 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 2BFY C 798 840 UNP O13024 INCEA_XENLA 798 840 DBREF 2BFY D 798 840 UNP O13024 INCEA_XENLA 798 840 SEQADV 2BFY VAL A 96 UNP Q7ZYT9 GLY 96 ENGINEERED MUTATION SEQADV 2BFY VAL B 96 UNP Q7ZYT9 GLY 96 ENGINEERED MUTATION SEQRES 1 A 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 A 284 ASP ASP PHE ASP ILE VAL ARG PRO LEU GLY LYS GLY LYS SEQRES 3 A 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 A 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 A 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 A 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 A 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 A 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 A 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 A 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 A 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 A 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 A 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 A 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 A 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 A 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 A 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 A 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 A 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 A 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 A 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 A 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 B 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 B 284 ASP ASP PHE ASP ILE VAL ARG PRO LEU GLY LYS GLY LYS SEQRES 3 B 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 B 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 B 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 B 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 B 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 B 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 B 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 B 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 B 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 B 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 B 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 B 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 B 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 B 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 B 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 B 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 B 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 B 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 B 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 B 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 C 43 ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN ALA SEQRES 2 C 43 ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP ARG SEQRES 3 C 43 MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU LEU SEQRES 4 C 43 PHE ASN LYS SER SEQRES 1 D 43 ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN ALA SEQRES 2 D 43 ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP ARG SEQRES 3 D 43 MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU LEU SEQRES 4 D 43 PHE ASN LYS SER MODRES 2BFY TPO A 248 THR PHOSPHOTHREONINE MODRES 2BFY TPO B 248 THR PHOSPHOTHREONINE HET TPO A 248 11 HET TPO B 248 11 HET H1N A1357 37 HET H1N B1357 37 HETNAM TPO PHOSPHOTHREONINE HETNAM H1N N-[2-OXO-3-((E)-PHENYL{[4-(PIPERIDIN-1-YLMETHYL) HETNAM 2 H1N PHENYL]IMINO}METHYL)-2,6-DIHYDRO-1H-INDOL-5- HETNAM 3 H1N YL]ETHANESULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN H1N HESPERADIN FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 H1N 2(C29 H32 N4 O3 S) FORMUL 7 HOH *383(H2 O) HELIX 1 1 THR A 89 ASP A 91 5 3 HELIX 2 2 LYS A 126 GLU A 132 1 7 HELIX 3 3 VAL A 134 SER A 146 1 13 HELIX 4 4 LEU A 178 GLY A 186 1 9 HELIX 5 5 ASP A 189 GLU A 209 1 21 HELIX 6 6 LYS A 218 GLU A 220 5 3 HELIX 7 7 THR A 252 LEU A 256 5 5 HELIX 8 8 PRO A 257 GLU A 262 1 6 HELIX 9 9 LYS A 269 GLY A 285 1 17 HELIX 10 10 SER A 293 ASN A 303 1 11 HELIX 11 11 SER A 313 LEU A 324 1 12 HELIX 12 12 HIS A 327 ARG A 331 5 5 HELIX 13 13 PRO A 333 GLU A 339 1 7 HELIX 14 14 HIS A 340 SER A 347 1 8 HELIX 15 15 THR B 89 ASP B 91 5 3 HELIX 16 16 LYS B 126 LYS B 131 1 6 HELIX 17 17 VAL B 134 SER B 146 1 13 HELIX 18 18 LEU B 178 GLY B 186 1 9 HELIX 19 19 ASP B 189 ARG B 210 1 22 HELIX 20 20 LYS B 218 GLU B 220 5 3 HELIX 21 21 THR B 252 LEU B 256 5 5 HELIX 22 22 PRO B 257 GLU B 262 1 6 HELIX 23 23 LYS B 269 GLY B 285 1 17 HELIX 24 24 SER B 293 ASN B 303 1 11 HELIX 25 25 SER B 313 LEU B 324 1 12 HELIX 26 26 HIS B 327 ARG B 331 5 5 HELIX 27 27 PRO B 333 GLU B 339 1 7 HELIX 28 28 HIS B 340 SER B 347 1 8 HELIX 29 29 GLY C 804 LYS C 817 1 14 HELIX 30 30 ASP C 820 THR C 827 1 8 HELIX 31 31 LYS C 832 PHE C 837 1 6 HELIX 32 32 LEU D 807 LYS D 817 1 11 HELIX 33 33 ASP D 820 TYR D 825 1 6 HELIX 34 34 LYS D 832 PHE D 837 1 6 SHEET 1 AA 5 PHE A 93 GLY A 102 0 SHEET 2 AA 5 GLY A 105 GLU A 112 -1 O GLY A 105 N GLY A 102 SHEET 3 AA 5 PHE A 117 PHE A 125 -1 O PHE A 117 N GLU A 112 SHEET 4 AA 5 ARG A 165 LEU A 170 -1 O ILE A 166 N LEU A 124 SHEET 5 AA 5 MET A 156 HIS A 161 -1 N TYR A 157 O MET A 169 SHEET 1 AB 3 GLY A 176 GLU A 177 0 SHEET 2 AB 3 LEU A 222 MET A 224 -1 N MET A 224 O GLY A 176 SHEET 3 AB 3 LEU A 230 ILE A 232 -1 O LYS A 231 N LEU A 223 SHEET 1 AC 2 VAL A 212 ILE A 213 0 SHEET 2 AC 2 VAL A 239 HIS A 240 -1 O VAL A 239 N ILE A 213 SHEET 1 BA 5 PHE B 93 GLY B 102 0 SHEET 2 BA 5 GLY B 105 GLU B 112 -1 O GLY B 105 N GLY B 102 SHEET 3 BA 5 PHE B 117 PHE B 125 -1 O PHE B 117 N GLU B 112 SHEET 4 BA 5 ARG B 165 LEU B 170 -1 O ILE B 166 N LEU B 124 SHEET 5 BA 5 MET B 156 HIS B 161 -1 N TYR B 157 O MET B 169 SHEET 1 BB 3 GLY B 176 GLU B 177 0 SHEET 2 BB 3 LEU B 222 MET B 224 -1 N MET B 224 O GLY B 176 SHEET 3 BB 3 LEU B 230 ILE B 232 -1 O LYS B 231 N LEU B 223 SHEET 1 BC 2 VAL B 212 ILE B 213 0 SHEET 2 BC 2 VAL B 239 HIS B 240 -1 O VAL B 239 N ILE B 213 LINK C ARG A 247 N TPO A 248 1555 1555 1.33 LINK C TPO A 248 N MET A 249 1555 1555 1.62 LINK C ARG B 247 N TPO B 248 1555 1555 1.32 LINK C TPO B 248 N MET B 249 1555 1555 1.63 SITE 1 AC1 19 LEU A 99 LYS A 101 GLY A 102 LYS A 103 SITE 2 AC1 19 ALA A 120 LYS A 122 LEU A 154 GLU A 171 SITE 3 AC1 19 PHE A 172 ALA A 173 PRO A 174 ARG A 175 SITE 4 AC1 19 GLY A 176 GLU A 177 LEU A 223 ALA A 233 SITE 5 AC1 19 HOH A2006 HOH A2036 HOH A2037 SITE 1 AC2 15 ARG B 97 LEU B 99 GLY B 100 LYS B 101 SITE 2 AC2 15 LYS B 103 ALA B 120 LYS B 122 LEU B 154 SITE 3 AC2 15 GLU B 171 PHE B 172 ALA B 173 PRO B 174 SITE 4 AC2 15 GLY B 176 LEU B 223 ALA B 233 CRYST1 45.945 67.044 116.462 90.00 96.51 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021765 0.000000 0.002485 0.00000 SCALE2 0.000000 0.014916 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008642 0.00000